Followers | 646 |
Posts | 10,654 |
Boards Moderated | 2 |
Alias Born | 03/07/2015 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
close to a million in 15 min...not bad....nasty spread games....lets overcome them now by enriching our portfolio on the ask
nice feature of amazon...where/how can you track on the site?
tx
starting off with a 700k .0475 wall....games...an up friday ahead with this stupidity statement
Good call....I do not think the volume will pick up, though. It might very well from next week on (which translates into rapid climb)....so get on board
I called Fidelity brokerage specialist to inquire as to what information they base publication of these tentative days for some OTC stocks on. They said that is based on three things 1) previous timely SEC filings 2) being current 3) Info from company. When I asked specifically about ECIG they put me on hold for 10 min and then said its 1) and 2) but they have no record as to whether the company gave this date. When I asked about which date Fidelity posted this date they said they do not see that in their files (similarly, I did not get reliable info on why they changed the 10k date last week for ECIG from the 9th to the 7th). In other words (and it would not surprise me if TD Ameritrade has no info either on why they, too, list earnings release as March 7th) either these days are "made up" or companies can post anticipated dates somewhere (with the SEC; or similar) which some non-disclosed department in bigger brokerage firms has access to.
Weird, but we will find out on March 7th and learn from it. Among ECIG longs the consensus is that ECIG will file in the last week of March.
Hearing to approve Alpha's stalking-horse sale plan postponed again
Houston (Platts)--3 Mar 2016 536 pm EST/2236 GMT
The already rescheduled US bankruptcy court hearing to approve Alpha Natural Resources' plan to sell its core assets to a stalking-horse bidder has been postponed again.
http://www.platts.com/latest-news/coal/housto...e-21038610
The coal miner on Thursday confirmed the court had canceled the hearing, which had been scheduled for that day, but declined to comment.
The US Bankruptcy Court for the Eastern District of Virginia was first scheduled to hear arguments February 23 on Alpha's $500 million proposal to sell a combination of its top coal mines to a group made up of its senior lenders. The hearing was subsequently postponed to Thursday.
No new date for the hearing has been announced.
There were 16 objections to Alpha's stalking-horse plan, including motions by the West Virginia Department of Environmental Protection, the United Mine Workers of America Health and Retirement Funds, and multiple land and lending entities.
In Alpha's proposed plan, the company stated that the stalking-horse bid is not final and is open to competitive bidding, with a March 28 deadline set.
Think Im out of my 15 posts today...but good day to all...and NICK: You really believe we see a correction, I don't think so..its just a little swing with day old limit bids getting filled...and we havent reached the EOD yet...still running smooth the upper bollinger IMO
thats the usual morning routine before the afternoon runs...steady up!
LOL...no...had to sell just some few hundred K...and of course over days and on high ask only....the richer longs don't sell at all (100% locked until further notice/ 20cents up) and guys like me don't make an impact...I will keep 80% of my shares locked since I will try to hold 1M shares beyond 10cents and 1M shares up to dollar land few years from now
no worries
in that context...where are the big longs?...any plans to answer "the ask"
great....I'm back down at 2M shares (since I had to cash out some for mortgage etc...but at least have a realized gain of $23000 already)....now I can only buy little bits on the ask which I just started to do 10 min ago
i'm buying some now...want to see it xing the 5 in 30 min :)
Yes, the daily a little early today...but even better...lets get it over with now to mid morning
way before
sounds good....0.045 is not lower 4s...yes, above middle 4s we might see for an hour or so
no..we won't
nothing unusual...it fluctuates for weeks between 38% and 65%
Q4 16 to 17 million; Q1 19 to 21 million ((9 weeks from now)
Next week we can expect the regular monthly update on
1) Revenue
2) Prescriptions fills
3) 340B contract distribution initiation
4) other developments
probably wednesday or thursday
progressive grows revenue yoy-most undervalued pharmacy stock on the market today
http://www.smarteranalyst.com/2016/02/19/progressive-care-inc-grows-revenue-24-yoy-most-undervalued-pharmacy-stock-on-the-market-today/
A company that specializes in the service of patients with special needs such as providing HIV medication and therapies can be found in South Florida. Though it is still in earlier phases, Progressive Care Inc (OTCMKTS:RXMD) operating through its wholly owned subsidiary, PharmCo LLC generated more than $1million in revenue per month in 2015 and furthermore the company has been surpassing monthly milestones and quarterly benchmarks on a continuous basis. The company’s mission is to treat these patients with the utmost of care, privacy and respect through increasing access to vital medications and equipment, raising awareness, and providing education and other services to local communities and long term care institution.
For fiscal year 2014, Progressive Care had over $11 M in revenues and in 2015, the Company has not only been able to increase revenues, but also attain positive operating income for the first time since 2010. The Company’s cash flow now supports the operation and has allowed for investments and improvements to PharmCo’s facility and work-flow. As of 09/30/2015 cash on hand was $270,328 and through the first nine months of 2015, PharmCo, LLC has recorded nearly $350,000 in net income.
PharmCo, LLC offers a diverse range of products and services to retail customers, patients with specialty needs, long-term care facilities, rehab centers, doctors’ offices and clinics. These products include general pharmaceuticals and specialty medications, compounded medications, over-the-counter products, and durable medical equipment.
Stock Performance
Since June the stock has seen an increase in liquidity and times of significant price movement. I speculate that due to the active 3(a)(10) transaction during the majority of the last 5.5 months, the depressed price and restrictive resistance levels had affected the stock’s ability to increase in value. Following the announcement that the company had in fact completed this debt instrument, shares of Progressive began to realize price appreciation:
Since June 17, 2015 (not including the obvious outliers of June 25/26) the stock has climbed 536.36% as of Wednesday’s (Feb. 17, 2016) closing price of $0.035. The stock has also been on a very consistent uptrend since announcing a positive reception on its first road show as well as the announcement that it had completed its 3(a)(10) transaction.RXMD Chart 217
2015 Operating Performance & Growth
Through the first six months of 2015, general pharmaceuticals and compounds comprised 99% of the company’s revenues, with each representing 85% and 14% respectively. The facility currently fills approximately 50,000 prescriptions per quarter with minimal square footage devoted to compounding and long-term care operations. Due to dramatic increases in demand, PharmCo initiated plans to expand the pharmacy this past year.
In addition to the positive results from the first 6 months, RXMD continued growth through results from the first nine months of 2015 as well. The company reached nearly $10 million in revenues, achieved positive cash flow and operating profitability. Furthermore, in the third quarter of 2015, the company posted a 14% increase in revenue over the same quarter last year at approximately $3.3 million. In the fourth quarter, Progressive saw yet another record quarter with revenues of nearly $4million ($3.9mm) and closing the year with more than $13.5million in net pharmacy revenues; a 24% increase year over year. The company also boasts a healthy mix of new and refill prescriptions with each amounting to close to 50% of monthly sales. Maintaining this mixture has been key to PharmCo’s long-term growth and success.
Risk Factors
Unlike other Bulletin Board stocks, Progressive does not hold aged debt as this was eliminated through a 3(a)(10) transaction. Details of the completion and debt extinguishment were announced in late December however, this has not yet been reflected in any financial statements (formal Q4 and Y2015 statements have not yet been posted).
Conclusion
Whether undervalued growth company or candidate for acquisition, RXMD has stood out among the fragmented and traditionally privately held pharmacy organizations to offer investment potential should the right investor realize it. The company’s continued growth, positive market sentiment, and positive price movement over the last 7 months all weigh on an investment decision.
Highlights of the day (other than green and in the 0.05s):
Interview with the CEO is a must read not only for investors but to understand the market, the sector, the needs, the future of the healthcare platform in developed countries
a 20+cents stock price on sale for one more hour...ladies and gentlemen
Interview with the CEO is a must read not only for investors but to understand the market, the sector, the needs, the future of the healthcare platform in developed countries
lets just get it going for the anticipated afternoon rise
ok now...lets get it going for the afternoon rise
correct...agree
Please compare your prvious posts to the actual pps moves at the time...facts over prediction faults
agree....I assume it would be to increase your existing position by some 10-20% or so, then I would do it (wouldn't tell a newbie, though, to put all in at once but depending on the intraday moves to get as many in the 4s as possible)
no sticky by boothhip...please email admins with request to replace (and date when he posted last)
the 11/22 and 2/9 are outdated and should be replaced (stickied by bolt and clearly)
why don't you buy the 25M on the ask (only $2500 needed)
Hi MFN...i stickied INSTAS forecast (excellent)...I could only replace it (hesitantly)...only one sticky per mod, unfortunately....if no other mod stickies the Mars interview in the next hours I could replace?
few 4s, lots of 3s IMO...steady
You are right....whith his background he could have gotten the top position in a global company with 10 times the total compensation from ECIG and just like before at MOLSON.
Why did he decide to turn ECIG around...the answer is legacy...in his age with his resume he has accomplished most in the business world. Now comes something different. Some people write history because they are the founders of start ups. O'Neil wants to link his name to the miraculous success story of the biggest global company on the market for e-cigs and vape devices and the only morally legitimate one (independent one from big tobacco) in the year 2025:::: EGIG INTERNATIONAL
This is the BIGGEST driver imaginable....shipping/distribution to all states.
So forget about 20 cents target....we are talking 50M revenue/multiple dollar pps in very few years
was in rx??? no reason to leave whatshowever...here I will always keep 10M shares (independent of some flipping) for the long run....read my past posts on DRNK, anything possible
.....right now the annual revenue is ~800-~900k. http://www.nasdaq.com/symbol/drnk/revenue-eps
If distribution agreements partially bear fruit (and they will in Asia at least) then the revenue could be 2m annually and be used to cover obligations.....using a P/S ratio of ~3.5 (see below) in this sector with some 3B shares as O/S (assuming some more dilution; now O/S is ~1.8) then the fair market share value would be $ 0.0023.
Market Cap consideration for this sector; http://pages.stern.nyu.edu/~adamodar/New_Home...data.html:
Beverage (Alcoholic) 4.74 price/sales ratio
Beverage (Soft) 3.01 price/sales ratio
funny...ur right....even less flipping than yesterday...
no PM...12M shares
slowly...the MMs are still in control (boximg, bid/ask spread)....if they are lagging in sucess we will see a mild short squeeze in no time
Overdue certainly
oh no...this is the only solid company here that can have 50% moves in one day...the whole year I analyzed (not as an professional investor but as a scientist)